newsfilter
← Latest News
Business Wire·

Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells

– Observed response is excellent surrogate of the potential of Gemini in target indications – – Equivalent response anticipated in Phase 1b study CKD patients – Revelation Biosciences, Inc. (NASDAQ:REVB) (the